A team of Canadian researchers from Universite de Montreal has designed and validated a new class of drug transporters made of DNA that are 20,000 times smaller than a human hair and that could improve how cancers and other diseases are treated
The platform, described in a new paper in the journal ACS Infectious Diseases, could help to address the ongoing antibiotic resistance crisis, say the scientists. They modified and then tested red blood cells as a carrier for one of the world's only remaining resistance-proof antibiotics: Po
Weill Cornell Medicine researchers have developed a computational method to map the architecture of human tissues in unprecedented detail. Their approach promises to accelerate studies on organ-scale cellular interactions and could enable powerful new diagnostic strategies for a wide range o
Finding cancer-related indicators is a highly effective method for determining diagnosis, prognosis, and response to treatment. These markers may now be found in patient samples like blood and urine thanks to modern technology, offering a non-invasive way to monitor and assess patients.
The VII Congress of the Leaders of World and Traditional Religions held in Astana appealed to world leaders to stop conflicts and bloodshed in all corners of the planet.
Recently, researchers have found that the germ and several other clinically significant bacteria, including as Staphylococcus aureus, Escherichia coli, and Klebsiella pneumoniae, were susceptible to the bacterial killing action of hydroquinine, an organic chemical found in the bark of some t
During a recent interview, George RR Martin has said that he would have picked a different starting point in the story for HBO's 'House of the Dragon' series.
The committee arrived at a decision after going through the inspection/examination of the records received from the hospital administration, added the Chief Medical Officer.
Dementia encompasses a range of neurodegenerative conditions that lead to memory loss and cognitive deficiencies and affect some 55 million people worldwide. Yet despite its prevalence, there are few effective treatments, in part because scientists still don't understand how exactly dementia